| Literature DB >> 33441127 |
Yazan Ranneh1, Abdah Md Akim2, Hasiah Ab Hamid3, Huzwah Khazaai3, Abdulmannan Fadel4, Zainul Amiruddin Zakaria3, Mohammed Albujja5, Mohd Fadzelly Abu Bakar1.
Abstract
Inflammation is the main key role in developing chronic diseases including cancer, cardiovascular diseases, diabetes, arthritis, and neurodegenerative diseases which possess a huge challenge for treatment. With massively compelling evidence of the role played by nutritional modulation in preventing inflammation-related diseases, there is a growing interest into the search for natural functional foods with therapeutic and preventive actions. Honey, a nutritional healthy product, is produced mainly by two types of bees: honeybee and stingless bee. Since both types of honey possess distinctive phenolic and flavonoid compounds, there is recently an intensive interest in their biological and clinical actions against inflammation-mediated chronic diseases. This review shed the light specifically on the bioavailability and bioaccessibility of honey polyphenols and highlight their roles in targeting inflammatory pathways in gastrointestinal tract disorders, edema, cancer, metabolic and cardiovascular diseases and gut microbiota.Entities:
Keywords: Bioaccessibility; Bioactive compounds; Bioavailability; Chronic inflammation; Honey
Year: 2021 PMID: 33441127 PMCID: PMC7807510 DOI: 10.1186/s12906-020-03170-5
Source DB: PubMed Journal: BMC Complement Med Ther ISSN: 2662-7671